being developed to improve the quality of life for people with presbyopia by providing an alternative to reading glasses. CSF-1 is a preservative-free solution that contains a proprietary combination of low-dose pilocarpine and multi-faceted vehicle. Our solution aims for the optimal balance between efficacy, safety and comfort with the potential to improve near vision in people with presbyopia.
Clinical trial results to date have demonstrated significant improvements in near vision and a superior safety profile, supporting potential quality of life improvement in people with presbyopia. In a Phase 2b study, CSF-1 demonstrated exceptional near visual acuity with NO reduction of distance or night vision. This study also met the primary end-point, 3-line improvement in near vision (using the standard ETDRS chart).